Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

TTF-1 regulates α5 nicotinic acetylcholine receptor (nAChR) subunits in proximal and distal lung epithelium

Authors: Paul R Reynolds, Camille H Allison, Charles P Willnauer

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels comprised of five similar subunits that influence signal transduction and cell turnover. α5 is a structural subunit detected in many non-neuronal tissues; however, its function during pulmonary development is unknown.

Results

α5 was assessed by immunohistochemistry and RT-PCR in mouse lungs from embryonic day (E)13.5 to post-natal day (PN)20. From E13.5 to E18.5, α5 expression was primarily observed in primitive airway epithelial cells while mesenchymal expression was faint and sporadic. α5 expression was detected throughout the proximal lung at PN1 and extensively expressed in the peripheral lung at PN4, an early stage of murine alveologenesis. An interesting shift occurred wherein α5 expression was almost undetectable in the proximal lung from PN4-PN10, but significant localization was again observed at PN20. Transcriptional control of α5 was determined by assessing the activity of reporters containing 2.0-kb and 850-bp of the mouse α5 promoter. Because perinatal expression of α5 was abundant in bronchiolar and alveolar epithelium, we assessed transcriptional control of α5 in Beas2B cells, a human bronchiolar epithelial cell line, and A-549 cells, an alveolar type II cell-like human epithelial cell line. Thyroid Transcription Factor-1 (TTF-1), a key transcription regulator of pulmonary morphogenesis, significantly increased α5 transcription by acting on both the 2.0-kb and 850-bp α5 promoters. Site-directed mutagenesis revealed that TTF-1 activated α5 transcription by binding specific TTF-1 response elements. Exogenous TTF-1 also significantly induced α5 transcription.

Conclusions

These data demonstrate that α5 is specifically controlled in a temporal and spatial manner during pulmonary morphogenesis. Ongoing research may demonstrate that precise regulation of α5 is important during normal organogenesis and misexpression correlates with tobacco related lung disease.
Literature
1.
Guazzi S, Proce M, DeFelice M, Damante G, Mattei MG, DiLauro R: Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990, 9:3631–3639.PubMedPubMedCentral
2.
Lazzaro D, Proce M, DeFelice M, DeLauro R: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991, 113:1093–110.PubMed
3.
Mizuno K, Gonzales FJ, Kimura S: Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1. Mol Cell Biol 1991, 11:4927–33.CrossRefPubMedPubMedCentral
4.
Zhou L, Lim L, Costa RH, Whitsett JA: Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J Histochem Cytochem 1996, 44:1183–1193.CrossRefPubMed
5.
Bohinski RJ, Bohinski RJ, DiLauro R, Whitsett JA: The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 1994, 14:5671–5681.CrossRefPubMedPubMedCentral
6.
Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzales FJ: The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996, 10:60–69.CrossRefPubMed
7.
Conti-Fine BM, Navaneetham D, Lei S, Maus MD: Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 2000, 393:279–94.CrossRefPubMed
8.
Zia S, Ndoye A, Nguyan VT, Grando SA: Nicotine enhances expression of the alpha3, alpha 4, alpha5, and alpha7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 1997, 97:243–62.PubMed
9.
Carlisle DL, Hopkins TM, Gaither-Davis A: Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res 2004, 5:27.CrossRefPubMedPubMedCentral
10.
Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, Wells G: Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 1996, 109:125–37.CrossRefPubMed
11.
West KA, Brognard J, Clark AS, et al.: Rapid Akt activation by nicotine nd a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J CLin Invest 2003, 111:81–90.CrossRefPubMedPubMedCentral
12.
Brunzell DH, Russell DS, Picciotto MR: In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J Neurochem 2003, 84:1431–41.CrossRefPubMed
13.
Minana MD, Montoliu C, Llansola M, Grisolia S, Felipo V: Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons. Neuropharmacology 1998, 37:847–57.CrossRefPubMed
14.
Bertrand D, Changeux J: Orthodontic correction of maxillary flaring using provisional restorations. Neurosciences 1995, 7:75–90.
15.
Lindstrom J: Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 1997, 15:193–222.CrossRefPubMed
16.
Reynolds PR, Hoidal JR: Temporal-spatial expression and transcriptional regulation of α 7 nicotinic acetylcholine receptor by thyroid transcription factor-1 and early growth response factor-1 during murine lung development. J Biol Chem 2005,280(37):32548–54.CrossRefPubMed
17.
18.
Gahring LC, Persiyanov K, Dunn D, Weiss R, Meyer EL, Rodgers SW: Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus. J Comp Neurol 2004, 468:334–46.CrossRefPubMed
19.
Rogers SW, Mandelzys A, Deneris ES, Cooper E, Heinemann S: The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF. J Neurosci 1992,12(12):4611–4623.PubMed
20.
Moser N, Mechawar N, Jones I, Gochberg-Sarver A, Orr-Urtreger A, Plomann M, Salas R, Molles B, Marubio L, Roth U, Maskos U, Winzer-Serhan U, Bourgeois JP, Le Sourd AM, De Biasi M, Schoeder H, Lindstrom J, Maelicke A, Changeux JP, Wevers A: Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem 2007,102(2):479–92.CrossRefPubMed
21.
Herber DL, Severance EG, Cuevas J, Morgan D, Gordon MN: Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue. J Histochem Cytochem 2004,52(10):1367–76.CrossRefPubMed
22.
Reynolds PR, Mucenski ML, Whitestt JA: Thyroid transcription factor (TTF)-1 regulates the expression of Midkine (MK) during lung morphogenesis. Dev Dyn 2003, 227:227–37.CrossRefPubMed
23.
Reynolds PR, Mucenski ML, LeCras TD, Nichols WC, Whitsett JA: Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 2004,279(35):37124–32.CrossRefPubMed
24.
Maus ADJ, Pereira EFR, Karachunski PI, Horton RM, Navaneetham D, Lei S, Albuquerque EX, Conti-Fine BM: Human and Rodent Bronchial Epithelial Cells Express Functional Nicotinic Acetylcholine Receptors. Mol Pharmacol 1998, 54:779–88.PubMed
25.
Wang Y, Pereira EFR, Maus ADG, Ostlie NS, Navaneetham D, Lei S, Albuquerque EX, Conti-Fine BM: Human Bronchial Epithelial and Endothelial Cells Express α7 Nicotinic Acetylcholine Receptors. Mol Pharmacol 2001, 60:1201–9.PubMed
26.
Proskocil BJ, Sekhon HS, Jia Y, Savchenko V, Blakely RD, Lindstrom J, Spindel ER: Acetylcholine Is an Autocrine or Paracrine Hormone Synthesized and Secreted by Airway Bronchial Epithelial Cells. Endocrinology 2004, 145:2498–06.CrossRefPubMed
27.
Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EX: Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 1997, 9:2734–42.CrossRefPubMed
28.
Ikegami M, Lewis JF, Tabor B, Rider ED, Jobe AH: Surfactant protein A metabolism in preterm ventilated lambs. Am J Physiol 1992,262(6 pt 1):L765–72.PubMed
29.
Perl AKT, Whitsett JA: Molecular mechanisms controlling lung morphogenesis. Clin Genet 1999, 56:14–27.CrossRefPubMed
30.
Keijzer R, van Tuyl M, Meijers C, Post M, Tibboel D, Grosveld F, Koutsourakis M: The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development. Development 2001, 128:503–511.PubMed
31.
Maeda Y, Dave V, Whitsett JA: Transcriptional control of lung morphogenesis. Physiol Rev 2007, 87:210–44.CrossRef
32.
Arredondo J, Chernyavsky Al, Jolkovsky DL, Pinkerton KE, Grando SA: Receptor-mediated tobacco toxicity: acceleration of sequential expression of alpha5 and alpha7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke. FASEB J 2008,22(5):1356–68.CrossRefPubMed
33.
Benowitz NL, Kuyt F, Jacob P: Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther 1982, 32:758–64.CrossRefPubMed
34.
35.
Hsia SH, Schulman SR, Meliones JN, Canada AT, Chen SC: Effects of maternal nicotine exposure on branching morphogenesis of mouse fetal lung: in vivo and in vitro studies. Acta Paediatr Taiwan 2003, 44:150–4.PubMed
36.
37.
Tager IB, Hanrahan JP, Tostesan TD, et al.: Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis 1993, 147:811–17.CrossRefPubMed
38.
Sandberg K, Poole SD, Hamdan A, Arbogast P, Sundell HW: Altered lung development after prenatal nicotine exposure in young lambs. Pediatr Res 2004, 56:432–9.CrossRefPubMed
39.
Bierut LJ: Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24–25. Trends Pharmacol Sci 2009, 31:46–51.CrossRefPubMedPubMedCentral
40.
Spitz MR, Amos CI, Dong Q, Lin J, Wu X: The CHRNA5-A3 region on chromosome 15q24–25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 2008, 100:1552–1556.CrossRefPubMedPubMedCentral
41.
Pillai SG, Ge D, Zhu G, Kong X, Shianna K, Need A, Feng S, Hersh C, Bakke P, Gulsvik A, Ruppert A, Lodrup C, Roses A, Anderson W, Investigators ICGN, Rennard SI, Lomas DA, Silverman EK, Goldstein DB: A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5:e1000421.CrossRefPubMedPubMedCentral
Metadata
Title
TTF-1 regulates α5 nicotinic acetylcholine receptor (nAChR) subunits in proximal and distal lung epithelium
Authors
Paul R Reynolds
Camille H Allison
Charles P Willnauer
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-175

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue

Research

Neurotrophins and neurotrophin receptors in pulmonary sarcoidosis - granulomas as a source of expression

Research

Effect of acute hypoxia on respiratory muscle fatigue in healthy humans

Research

Disrupted postnatal lung development in heme oxygenase-1 deficient mice

Research

Identification of lung cancer with high sensitivity and specificity by blood testing

Research

Decline in air pollution and change in prevalence in respiratory symptoms and chronic obstructive pulmonary disease in elderly women

Research

Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits